SUBSCRIBE
SUBSCRIBE

Newsfile Corp

IN THE PRESS
FDA
NervGen Pharma Receives FDA Authorization to Expand Enrollment of Males and Premenopausal Females in Phase 1 Clinical Trial of NervGen’s NVG-291
October 25, 2022
 · 
7 min read
Drug Development
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases
October 25, 2022
 · 
9 min read
Business
Appointment of Kathleen Rotika to PreveCeutical’s Board of Directors
October 20, 2022
 · 
5 min read
NervGen Pharma Presenting at Upcoming Scientific Meetings
October 20, 2022
 · 
5 min read
Business
Sona Announces Commercial Agreement with Siva Therapeutics
October 20, 2022
 · 
6 min read
Hemostemix Announces NCP-01 Study to Address a $10 Billion Pain Market
October 19, 2022
 · 
7 min read
Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance
October 18, 2022
 · 
5 min read
Business
Telo Genomics Engages Key Opinion Leader to Form and Chair Myeloma Advisory Board
October 18, 2022
 · 
6 min read
Halberd Laser Therapy Eliminates over 90% of Multiple Antibiotic Resistant Bacteria in Minutes
October 18, 2022
 · 
3 min read
Drug Development
Kiora Pharmaceuticals Announces Publication of Phase 1 Trial Results for KIO-100 as a Treatment for Ocular Inflammatory Disease
October 17, 2022
 · 
6 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us